companydata.dkcompanydata.dk

ICEPHARMA A/S: Financial statements 2020

CVR: 36393459

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

ICEPHARMA A/S (CVR 36393459) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -2,207,233 and a net result of DKK -5,660,020 compared with DKK -7,690,041 the year before. Equity in the 2020 report amounted to DKK 7,483. The solvency ratio was 0.4%. The company had 5 employees in the financial year.

Gross Profit
DKK -2,207,233
Profit/Loss
DKK -5,660,020
Equity
DKK 7,483
Total Assets
DKK 1,834,416
Employees
5

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020--2.2 mio.-5.7 mio.7 t.5
2019--3.9 mio.-7.7 mio.581 t.5
2018--3.6 mio.-7.2 mio.829 t.5
2017--722 t.-4.8 mio.-579 t.6
2016-2.2 mio.-3.8 mio.188 t.5

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is ICEPHARMA A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

ICEPHARMA A/S: The 2019 annual report is outJul 17, 2020

ICEPHARMA A/S has published its annual report for 2019. Gross profit came to DKK -3,925,725, and the net result was DKK -7,690,041.

About ICEPHARMA A/S

ICEPHARMA A/S is a Danish company of the type Aktieselskab based in Taastrup, founded in 2014. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Hörður Þórhallsson. The board consists of Kristján Johannsson (chair), Jóhann Ingi Kristjánsson and Petrea Ingileif Gudmundsdottir. The company is owned by Eignarhaldsfélagið Lyng ehf. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 1,000,033 and a net result of DKK 1,883,876 compared with DKK -3,562,543 the year before. Equity in the 2025 report amounted to DKK 10,304,500.

Source: annual report 2025, Danish Business Authority